Performance analysis of Iovance Biotherapeutics (IOVA)
Annual Return
Over the past 3 years, IOVA has had an average annual return of -22.49%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, IOVA has had an average annual return of -25.13%, underperforming the benchmark SPY, which returned +14% annual.
Over the past 10 years, IOVA has had an average annual return of -7.19%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Oct 15, 2010, IOVA has had an average annual return of -18.96%, underperforming the benchmark SPY, which returned +14.67% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +50.40% | -63.15% | -8.93% | +27.19% | -66.51% | -58.87% | +67.65% | +212.55% | +10.73% | +15.03% | -9.97% | -1.82% |
| 2014 | 2013 | 2012 | 2011 | 2010 | |||||||
| -25.13% | -52.25% | -78.00% | -20.00% | +13.64% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.45% | +51.29% | -9.12% | -4.39% | +22.30% | +0% | +50.40% | ||||||
| 2025 | -20.95% | -27.63% | -21.30% | +7.59% | -51.23% | -1.89% | +50% | -13.25% | -2.96% | -9.14% | +25.70% | +10.22% | -63.15% |
| 2024 | -4.87% | +105.69% | -6.85% | -20.49% | -24.65% | -9.67% | +8.92% | +33.50% | -19.43% | +11.12% | -10.75% | -20.54% | -8.93% |
| 2023 | +24.61% | -8.43% | -16.29% | -7.57% | +54.97% | -19.50% | +3.13% | -16.82% | -24.59% | -16.18% | +59.08% | +33.88% | +27.19% |
| 2022 | -12.74% | -5.88% | +6.25% | -9.05% | -55.41% | +63.52% | +5.48% | -7.93% | -10.67% | -2.53% | -31.45% | -0.17% | -66.51% |
| 2021 | -5.52% | -14.91% | -15.13% | -0.69% | -40.94% | +40.11% | -14.38% | +8.05% | +2.47% | -1.43% | -22.99% | +1.94% | -58.87% |
| 2020 | -21.46% | +51.42% | -9.06% | +7.42% | -0.21% | -14.47% | +5.93% | +14.64% | -1.22% | +8.39% | +8.75% | +19.56% | +67.65% |
| 2019 | +3.35% | +12.26% | -7.39% | +19.77% | +43.44% | +50% | +0.27% | -14.54% | -13.35% | +16.07% | +8.02% | +21.25% | +212.55% |
| 2018 | +94.50% | +11.53% | -2.60% | -14.19% | +0.68% | -12.28% | +10.91% | +24.63% | -36.42% | -19.35% | +6.55% | -8.42% | +10.73% |
| 2017 | +4.27% | +5.46% | -2.59% | -7.98% | -24.88% | +42.74% | -20.36% | -1.69% | +34.80% | +0.28% | +16.41% | -11.66% | +15.03% |
Drawdown analysis of Iovance Biotherapeutics (IOVA)
The maximum drawdown for the IOVA was -99.37%, occurring on Apr 12, 2013. This drawdown has not yet recovered.
The current IOVA drawdown is -97.42%.
Since Oct 15, 2010 IOVA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.37% | Jun 7, 2011 | 464 | Apr 12, 2013 | Ongoing | Ongoing | Ongoing |
| -13.52% | Nov 15, 2010 | 4 | Nov 19, 2010 | 7 | Dec 1, 2010 | 11 |
| -12.70% | Feb 9, 2011 | 22 | Mar 14, 2011 | 33 | Apr 29, 2011 | 55 |
| -9.09% | Oct 15, 2010 | 5 | Oct 22, 2010 | 16 | Nov 15, 2010 | 21 |
| -7.56% | Dec 1, 2010 | 5 | Dec 8, 2010 | 4 | Dec 14, 2010 | 9 |
| -6.99% | May 25, 2011 | 3 | May 31, 2011 | 2 | Jun 2, 2011 | 5 |
| -6.30% | Apr 29, 2011 | 2 | May 3, 2011 | 10 | May 17, 2011 | 12 |
| -2.22% | May 18, 2011 | 1 | May 19, 2011 | 1 | May 20, 2011 | 2 |